Use of genomic testing continues to increase to seek to explain the reasons for and drivers of cancer. Some aspects of the newest broad study related to inherited mutations in persons with mesothelioma are summarized by David Schwartz and me in a September 6, 2018 post at the ToxicoGenomica blog.